Procter & Gamble has announced a string of organization changes, including the retirement of 37-year company veteran Dimitri Panayotopoulos, vice chairman and adviser to the chairman and CEO, effective Jan. 2, 2014.
Skin care brand Beiersdorf reported that its consumer business segment achieved “significant, above-market sales growth” during the first nine months of 2013, with both Nivea and Eucerin enjoying a boost in sales.
When it comes to laws and regulations, what happens in Europe stays in Europe generally, and doesn’t have much bearing on the United States. But a recent win in Europe for U.S. drug maker Hospira could have some implications for the United States as well.
Nearly all doctors say that the sharp growth in Type 2 diabetes around the world and the obesity epidemic are linked to excess sugar consumption, according to a new report by the Credit Suisse Research Institute.
European regulators have approved the European Union's first biosimilar monoclonal antibody. The new product, made by U.S.-based Hospira, comes seven years after the approval of Europe's first biosimilar.
The global prestige beauty market experienced mixed results in the first half of 2013 but the U.S. prestige beauty market posted an 8% gain during the first six months of the year, according to the NPD Group.
Inspired by the open-air markets of Europe, Giant Eagle opened its first Market District food store in Northeast Ohio — a 94,000-square-foot culinary, dining and shopping destination — on Thursday in the Solon Village Shopping Center that the company will staff with a licensed skin care professional and dietitian who will conduct health-and-wellness activities in the store.
Reckitt Benckiser named Alexander Lacik, 48, to the position of president, Reckitt Benckiser North America, effective June 2013. Lacik reports directly to Rob de Groot, EVP Europe and North America, and will be a part of the ENA leadership team.
Sandoz has started a late-stage clinical trial of a biosimilar version of a drug used to treat autoimmune disorders, hoping the results will support its efforts to win regulatory approval in the United States and Europe.
Molson Coors Brewing Company is showcasing a global lineup of product innovations designed to expand its portfolio and provide consumers with variety as the summer season kicks off. The company has planned new releases in Canada, Europe and the United States.
Energizer Holdings had sales of $1.095 billion in second quarter 2013, a 0.5% decrease from second quarter 2012, and $2.28 billion for the first six months of the fiscal year, which ended March 31, also a 0.5% decrease from the same period last year, the company said.
Generic drug maker Hospira marked its fifth year marketing knock-off versions of biotech drugs in Europe Wednesday as it presented at the 2013 Biotechnology Industry Organization International Convention this week.
It's official. During its most recent quarterly conference call with analysts, CVS Caremark revealed what many had anticipated: Its acquisition of privately held Brazilian drug store chain Drogaria Onofre was complete.